{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:22:49Z","timestamp":1780316569288,"version":"3.54.1"},"reference-count":43,"publisher":"Japan Atherosclerosis Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.5551\/jat.46821","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T22:25:31Z","timestamp":1547677531000},"page":"762-774","source":"Crossref","is-referenced-by-count":12,"title":["Serum Triglyceride Lipase Concentrations are Independent Risk Factors for Coronary Artery Disease and In-Stent Restenosis"],"prefix":"10.5551","volume":"26","author":[{"given":"Xiaolan","family":"Yu","sequence":"first","affiliation":[{"name":"Shanghai Municipality Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Physical examinations, The Sixth People\u2019s Hospital, School of Medicine, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory of Regeneromics, School of Pharmacy, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaorong","family":"Deng","sequence":"additional","affiliation":[{"name":"Laboratory of Regeneromics, School of Pharmacy, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Deng","sequence":"additional","affiliation":[{"name":"Shanghai Municipality Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ye","sequence":"additional","affiliation":[{"name":"Laboratory of Regeneromics, School of Pharmacy, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[{"name":"Laboratory of Regeneromics, School of Pharmacy, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[{"name":"Shanghai Municipality Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Perez-Mendez O, Pacheco HG, Martinez-Sanchez C and Franco M: HDL-cholesterol in coronary artery disease risk: function or structure? Clin Chim Acta, 2014; 429: 111-122","DOI":"10.1016\/j.cca.2013.12.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Field PA and Vasan RS: LDL-Cholesterol Is Not the Only Clinically Relevant Biomarker for Coronary Artery Disease or Acute Coronary Syndrome. Clin Pharmacol Ther, 2018; 104: 232-234","DOI":"10.1002\/cpt.1126"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, South V, Amin D, Perrone M and Rader DJ: A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet, 1999; 21: 424-428","DOI":"10.1038\/7766"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Wong H, Davis RC, Nikazy J, Seebart KE and Schotz MC: Domain exchange: characterization of a chimeric lipase of hepatic lipase and lipoprotein lipase. Proc Natl Acad Sci U S A, 1991; 88: 11290-11294","DOI":"10.1073\/pnas.88.24.11290"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Goldberg IJ: Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res, 1996; 37: 693-707","DOI":"10.1016\/S0022-2275(20)37569-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hirata K, Dichek HL, Cioffi JA, Choi SY, Leeper NJ, Quintana L, Kronmal GS, Cooper AD and Quertermous T: Cloning of a unique lipase from endothelial cells extends the lipase gene family. J Biol Chem, 1999; 274: 14170-14175","DOI":"10.1074\/jbc.274.20.14170"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Badellino KO, Wolfe ML, Reilly MP and Rader DJ: Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med, 2006; 3: e22","DOI":"10.1371\/journal.pmed.0030022"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sun L, Ishida T, Miyashita K, Kinoshita N, Mori K, Yasuda T, Toh R, Nakajima K, Imamura S and Hirata K: Plasma activity of endothelial lipase impacts high-density lipoprotein metabolism and coronary risk factors in humans. J Atheroscler Thromb, 2014; 21: 313-321","DOI":"10.5551\/jat.20131"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Santamarina-Fojo S, Gonzalez-Navarro H, Freeman L, Wagner E and Nong Z: Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol, 2004; 24: 1750-1754","DOI":"10.1161\/01.ATV.0000140818.00570.2d"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Dugi KA, Brandauer K, Schmidt N, Nau B, Schneider JG, Mentz S, Keiper T, Schaefer JR, Meissner C, Kather H, Bahner ML, Fiehn W and Kreuzer J: Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation, 2001; 104: 3057-3062","DOI":"10.1161\/hc5001.100795"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Liu Y, Xu J, Tao W, Yu R and Zhang X: A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient. J Atheroscler Thromb, 2019; 26: 136-144","DOI":"10.5551\/jat.44537"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Miyashita K, Nakajima K, Fukamachi I, Muraba Y, Koga T, Shimomura Y, Machida T, Murakami M and Kobayashi J: A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase. J Lipid Res, 2017; 58:1591-1597","DOI":"10.1194\/jlr.M075432"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hitsumoto T, Ohsawa H, Uchi T, Noike H, Kanai M, Yoshinuma M, Miyashita Y, Watanabe H and Shirai K: Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis. Atherosclerosis, 2000; 153: 391-396","DOI":"10.1016\/S0021-9150(00)00413-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Rip J, Nierman MC, Wareham NJ, Luben R, Bingham SA, Day NE, van Miert JN, Hutten BA, Kastelein JJ, Kuivenhoven JA, Khaw KT and Boekholdt SM: Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol, 2006; 26: 637-642","DOI":"10.1161\/01.ATV.0000201038.47949.56"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Saiki A, Oyama T, Endo K, Ebisuno M, Ohira M, Koide N, Murano T, Miyashita Y and Shirai K: Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. Diabetes Res Clin Pract, 2007; 76: 93-101","DOI":"10.1016\/j.diabres.2006.08.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Dugi KA, Schmidt N, Brandauer K, Ramacher D, Fiehn W and Kreuzer J: Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease. Atherosclerosis, 2002; 163: 127-134","DOI":"10.1016\/S0021-9150(01)00752-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Andrus B and Lacaille D: 2013 ACC\/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol, 2014; 63: 2886","DOI":"10.1016\/j.jacc.2014.02.606"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Shirakawa T, Nakajima K, Shimomura Y, Kobayashi J, Stanhope K, Havel P, Machida T, Sumino H and Murakami M: Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism. Clin Chim Acta, 2015; 440: 193-200","DOI":"10.1016\/j.cca.2014.07.020"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Judkins MP: Selective coronary arteriography. I. A percutaneous transfemoral technic. Radiology, 1967; 89: 815-824","DOI":"10.1148\/89.5.815"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ishida T, Miyashita K, Shimizu M, Kinoshita N, Mori K, Sun L, Yasuda T, Imamura S, Nakajima K, Stanhope KL, Havel PJ and Hirata K: ELISA system for human endothelial lipase. Clin Chem, 2012; 58: 1656-1664","DOI":"10.1373\/clinchem.2012.187914"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Shirakawa T, Nakajima K, Yatsuzuka S, Shimomura Y, Kobayashi J, Machida T, Sumino H and Murakami M: The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome. Clin Chim Acta, 2015; 440: 123-132","DOI":"10.1016\/j.cca.2014.10.029"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Pepe MS: The statistical evaluation of medical tests for classification and prediction, Oxford Univerisity Press, New York, USA, 2002","DOI":"10.1093\/oso\/9780198509844.001.0001"},{"key":"23","unstructured":"23) MH K: Multivariable analysis: a practical guide for clinicians, 2nd Ed, Cambridge University Press, New York, USA, 2006"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) An X, Yu D, Zhang R, Zhu J, Du R, Shi Y and Xiong X: Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study. Cardiovasc Diabetol, 2012; 11: 71","DOI":"10.1186\/1475-2840-11-71"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Inoue T, Croce K, Morooka T, Sakuma M, Node K and Simon DI: Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc Interv, 2011; 4: 1057-1066","DOI":"10.1016\/j.jcin.2011.05.025"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Nishio K, Fukui T, Tsunoda F, Kawamura K, Itoh S, Konno N, Ozawa K and Katagiri T: Insulin resistance as a predictor for restenosis after coronary stenting. Int J Cardiol, 2005; 103: 128-134","DOI":"10.1016\/j.ijcard.2004.08.039"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Badellino KO, Wolfe ML, Reilly MP and Rader DJ: Endothelial lipase is increased in vivo by inflammation in humans. Circulation, 2008; 117: 678-685","DOI":"10.1161\/CIRCULATIONAHA.107.707349"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Paradis ME, Badellino KO, Rader DJ, Deshaies Y, Couture P, Archer WR, Bergeron N and Lamarche B: Endothelial lipase is associated with inflammation in humans. J Lipid Res, 2006; 47: 2808-2813","DOI":"10.1194\/jlr.P600002-JLR200"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30) Huang Y, Li X, Wang M, Ning H, A L, Li Y and Sun C: Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study. Cardiovasc Diabetol, 2013; 12: 17","DOI":"10.1186\/1475-2840-12-17"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31) Hirano T: Pathophysiology of Diabetic Dyslipidemia. J Atheroscler Thromb, 2018; 25: 771-782","DOI":"10.5551\/jat.RV17023"},{"key":"31","unstructured":"32) Hitsumoto T, Takahashi M, Iizuka T and Shirai K: Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis. J Cardiol, 2006; 48: 65-73"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33) Sairyo M, Kobayashi T, Masuda D, Kanno K, Zhu Y, Okada T, Koseki M, Ohama T, Nishida M, Sakata Y and Yamashita S: A Novel Selective PPARalpha Modulator (SPPARMalpha), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice. J Atheroscler Thromb, 2018; 25: 142-152","DOI":"10.5551\/jat.39693"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34) Kobayashi J, Nohara A, Kawashiri MA, Inazu A, Koizumi J, Nakajima K and Mabuchi H: Serum lipoprotein lipase mass: clinical significance of its measurement. Clin Chim Acta, 2007; 378: 7-12","DOI":"10.1016\/j.cca.2006.12.003"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35) Miyashita K, Kobayashi J, Imamura S, Kinoshita N, Stanhope KL, Havel PJ, Nakajima K, Machida T, Sumino H, Nara M and Murakami M: A new enzyme-linked immunosorbent assay system for human hepatic triglyceride lipase. Clin Chim Acta, 2013; 424: 201-206","DOI":"10.1016\/j.cca.2013.06.016"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36) Andres-Blasco I, Herrero-Cervera A, Vinue A, MartinezHervas S, Piqueras L, Sanz MJ, Burks DJ and Gonzalez-Navarro H: Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis. J Endocrinol, 2015; 227: 179-191","DOI":"10.1530\/JOE-15-0219"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37) Hitsumoto T, Takahashi M, Iizuka T and Shirai K: Relationship between two AMI risk factors: low serum lipoprotein lipase mass and hypoadiponectinemia. J Atheroscler Thromb, 2011; 18: 148-156","DOI":"10.5551\/jat.6197"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38) Higgins LJ and Rutledge JC: Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase. Curr Atheroscler Rep, 2009; 11: 199-205","DOI":"10.1007\/s11883-009-0031-9"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39) Kobayashi J, Maruyama T, Masuda M and Shinomiya M: Effect of atorvastatin treatment on lipoprotein lipase mass in the pre-heparin plasma in Japanese hyperlipidemic subjects. Clin Chim Acta, 2001; 314: 261-264","DOI":"10.1016\/S0009-8981(01)00701-X"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40) Chen F, Maridakis V, O\u2019Neill EA, Hubbard BK, Strack A, Beals C, Herman GA and Wong P: The effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemia. Biomarkers, 2011; 16: 321-333","DOI":"10.3109\/1354750X.2011.561367"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41) Berk P, II, Hoogerbrugge N, Stolk RP, Bootsma AH, Jansen H and Group DS: Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant. Diabetes Care, 2003; 26: 427-432","DOI":"10.2337\/diacare.26.2.427"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42) Endo K, Miyashita Y, Saiki A, Oyama T, Koide N, Ozaki H, Otsuka M, Ito Y and Shirai K: Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia. J Atheroscler Thromb, 2004; 11: 341-347","DOI":"10.5551\/jat.11.341"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43) Kojima Y, Ishida T, Sun L, Yasuda T, Toh R, Rikitake Y, Fukuda A, Kume N, Koshiyama H, Taniguchi A and Hirata K: Pitavastatin decreases the expression of endothelial lipase both in vitro and in vivo. Cardiovasc Res, 2010; 87: 385-393","DOI":"10.1093\/cvr\/cvp419"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44) Tada H, Kobayashi J, Kawashiri MA, Miyashita K, Nohara A, Inazu A, Nakajima K, Mabuchi H and Yamagishi M: Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during threedrug lipid-lowering combination therapy. Lipids Health Dis, 2016; 15: 66","DOI":"10.1186\/s12944-016-0238-z"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/9\/26_46821\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T04:25:30Z","timestamp":1720931130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/9\/26_46821\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.46821","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,1]]}}}